PCOS and insulin resistance Polycystic ovary syndrome (PCOS) affects an estimated 710% of women of reproductive age, making it the most common hormonal disorder in this population
It all comes down to the FDA
Additionally, Semaglutide has been shown to be more effective than other chronic weight management medications that require daily dosing
These advancements position microneedle technology as a transformative approach for delivering GLP-1 receptor agonists, offering the potential to improve therapeutic adherence, minimize systemic side effects, and support decentralized care models for diabetes management [43]
semaglutide, the three molecules share a similar gastrointestinal profile, dominated by nausea during the titration phase, but retatrutide adds a specific tolerability signal related to its glucagon agonism
The journey began in the 1980s with research on Gila monster venom, culminating in the discovery of exendin-4, a stable, effective peptide for treating diabetes, demonstrating the progression from initial discovery to blockbuster diabetes medications
